Continues to Expand Viatris' Innovative Portfolio in Cardiovascular Diseases Leverages Viatris' Unique Global Infrastructure and Expertise Includes Opportunities to Leverage the Potential of ...
Processa Pharmaceuticals, Inc. has announced a licensing agreement with Intact Therapeutics for PCS12852, a novel 5-HT4 receptor agonist aimed at treating gastroparesis and gastrointestinal motility ...
PISCATAWAY, N.J. & REYKJAVIK, Iceland--(BUSINESS WIRE)--Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company, and Alvotech (NASDAQ: ALVO), a global biotech company ...
Sonder (SOND) also secures approximately $146 million in additional liquidity, including approximately $43 million convertible preferred equity investment to strengthen balance sheet “We're delighted ...
NEW YORK and NORTH CHICAGO, Ill., July 10, 2025 /PRNewswire/ -- IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (ABBV) today ...
“Traditional intellectual property frameworks, such as copyright and patents, often fall short when applied to AI technologies. Many datasets, like medical imaging, lack copyright protection, which ...
LAS VEGAS, Sept. 18, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), a Nevada-based corporation, and Austrianova (SGAustria Pte. Ltd.), a Singapore-based ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results